Prevalence and significance of anti-phosphatidylserine antibodies: A pooled analysis in 5992 patients

- The prevalence of aPS antibodies and their role when assessing clinical risk of APS is unknown.
- Data from 5992 patients tested for aPS antibodies included in 20 retrieved studies were analysed.
- aPS antibodies are frequently detected in patients with known APS, especially primary APS.
- The added diagnostic value and clinical role of aPS antibodies remains uncertain.